There are provided a method of producing a carbonyl compound by a flow type reaction, including introducing a triphosgene solution, a tertiary amine solution, and an active hydrogen-containing compound solution into flow channels different from each other to cause the respective solutions to flow inside the respective flow channels, joining the respective solutions that flow inside the respective flow channels simultaneously or sequentially so that a reaction between phosgene and an active hydrogen-containing compound occurs, and obtaining a carbonyl compound in a joining solution, in which a non-aqueous organic solvent is used as a solvent of each of the respective solutions and a compound having a cyclic structure is used as the tertiary amine; and a flow type reaction system that is suitable for carrying out this production method.

The present invention relates to a novel p62 ligand compound, a stereoisomer, hydrate, solvate or prodrug thereof, and a pharmaceutical or food composition for preventing or treating proteinopathies comprising the same as an active ingredient. The p62 ligand compound according to the present invention can be usefully used as a pharmaceutical composition for the prevention, amelioration or treatment of various proteinopathies by activating autophagy in cells and thus selectively eliminating in vivo proteins, organelles and aggregates.

The present disclosures are directed to processes for synthesizing (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide (“nirogacestat”).

Disclosed are an aniline anhydride, a preparation method therefor, and a polyaminoacid graft chain. In the presence of an acid binding agent, an addition-elimination reaction is carried out between N-phenyl amino acid and Boc anhydride to obtain N-phenyl-Boc-glycine; and under a nitrogen atmosphere, the N-phenyl-Boc-glycine is subject to cyclization to obtain the aniline anhydride. The polyaminoacid graft chain can be obtained using the aniline anhydride disclosed by means of chemical grafting and thus be covalently bonded with fiber. The fastness is high, the wearability of fabric is not affected, and the problem of low fastness of water-repellent fabric obtained by coating is solved. The polyaminoacid graft chain is biocompatible, naturally degradable and environmentally friendly, and is consistent with the current trend of developing green chemicals.

Disclosed are an aniline anhydride, a preparation method therefor, and a polyaminoacid graft chain. In the presence of an acid binding agent, an addition-elimination reaction is carried out between N-phenyl amino acid and Boc anhydride to obtain N-phenyl-Boc-glycine; and under a nitrogen atmosphere, the N-phenyl-Boc-glycine is subject to cyclization to obtain the aniline anhydride. The polyaminoacid graft chain can be obtained using the aniline anhydride disclosed by means of chemical grafting and thus be covalently bonded with fiber. The fastness is high, the wearability of fabric is not affected, and the problem of low fastness of water-repellent fabric obtained by coating is solved. The polyaminoacid graft chain is biocompatible, naturally degradable and environmentally friendly, and is consistent with the current trend of developing green chemicals.

The present disclosures are directed to processes for synthesizing (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide (“nirogacestat”).

The present disclosures are directed to processes for synthesizing (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide (“nirogacestat”).

The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.

The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.

The present invention relates to a compound obtained by a process comprising the following steps: (i) Reacting at least one isocyanate containing compound, in stoichiometric excess, with at least one isocyanate-reactive compound having a number average molecular weight equal to or higher than 400, resulting in the formation of at least one prepolymer having soft blocks and hard blocks in its structure, which prepolymer contains unreacted isocyanate monomer, (ii) Reacting said at least one prepolymer with a hydroxyl-ester compound or a hydroxyl-acid compound with the formation of hydroxyl-ester terminated prepolymer or hydroxyl-acid terminated prepolymer, and Ring-closing said hydroxyl-ester terminated prepolymer or hydroxyl-acid terminated prepolymer; (iii) Formation of said compound made of oxazolidinedione-terminated prepolymer and oxazolidinedione-terminated monomer, which is soluble in said oxazolidinedione-terminated prepolymer.